English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
A novel modulation method of LLC resonant converter with linear model and high efficiency Conference paper
Fang, Zhijian, Huang, Zhicong, Jing, Hang, Hu, Guozhen, Wang, Junhua, Tao, Liang. A novel modulation method of LLC resonant converter with linear model and high efficiency[C], 2019, 5152-5155.
Authors:  Fang, Zhijian;  Huang, Zhicong;  Jing, Hang;  Hu, Guozhen;  Wang, Junhua; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2 | Submit date：2022/05/17
High Efficiency  Linear Model  Llc Resonant Converter  Modulation  
Design, synthesis and anti-platelet aggregation activity study of ginkgolide-1,2,3-triazole derivatives Journal article
Cui,Jian, Hu,Lean, Shi,Wei, Cui,Guozhen, Zhang,Xumu, Zhang,Qing Wen. Design, synthesis and anti-platelet aggregation activity study of ginkgolide-1,2,3-triazole derivatives[J]. Molecules, 2019, 24(11).
Authors:  ; et al.
Favorite | TC[WOS]:6 TC[Scopus]:9  IF:4.2/4.6 | Submit date：2021/03/02
Ginkgolide  Inhibitor  Platelet-activating Factor Receptor  
A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor Journal article
Hu, Shengquan, Hu, Huihui, Mak, Shinghung, Cui, Guozhen, Lee, Mingyuen, Shan, Luchen, Wang, Yuqiang, Lin, Huangquan, Zhang, Zaijun, Han, Yifan. A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor[J]. FRONTIERS IN PHARMACOLOGY, 2018, 9.
Authors:  Hu, Shengquan;  Hu, Huihui;  Mak, Shinghung;  Cui, Guozhen;  Lee, Mingyuen; et al.
Favorite | TC[WOS]:17 TC[Scopus]:19  IF:4.4/5.0 | Submit date：2018/10/30
Alzheimer's Disease  Tetramethylpyrazine Derivative  Nmda Receptor  Neuroprotection  Oxidative Stress  Gsk3 Beta  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo, Baojian, Hu, Shengquan, Zheng, Chengyou, Wang, Hongyu, Luo, Fangcheng, Li, Haitao, Cui, Wei, Yang, Xifei, Cui, Guozhen, Mak, Shinghung, Choi, Tony Chung-Lit, Ma, Edmond Dik-Lung, Wang, Yuqiang, Lee, Simon Ming Yuen, Zhang, Zaijun, Han, Yifan. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. NEUROPHARMACOLOGY, 2017, 126, 12-24.
Authors:  Guo, Baojian;  Hu, Shengquan;  Zheng, Chengyou;  Wang, Hongyu;  Luo, Fangcheng; et al.
View | Adobe PDF | Favorite | TC[WOS]:18 TC[Scopus]:20  IF:4.6/4.5 | Submit date：2018/10/31
Parkinson's Disease  Su4312  Neuroprotection  Myocyte Enhancer Factor 2d  Monoamine Oxidase-b